Lifeway Foods reports US$57.1M net sales in Q3 2025

USA – Lifeway Foods, the leading U.S. supplier of kefir and fermented probiotic foods, has reported US$57.1 million in net sales, a 29% volume-led net sales increase on a comparable basis, driven by the Company’s flagship Lifeway Kefir.

Gross Profit Margin is 28.7%, up from 25.7% last year. Selling Expense: 8.8% of net sales, slightly up from last year, reflecting continued investment in marketing and distribution.

Net Income is US$3.5 million, or $0.23 per basic and diluted common share, compared to US$3.0 million, or $0.20 per basic and $0.19 per diluted share in the prior year.

Julie Smolyansky, President and Chief Executive Officer of Lifeway Foods said,”We delivered another exceptional quarter that further solidifies Lifeway’s dominant position in the kefir category and emphasizes the growing consumer demand for our flagship Lifeway Kefir and high-protein Lifeway Farmer Cheese,”

“With record net sales of US$57.1 million, well ahead of the previous high set in Q2, we have once again raised the bar for our business while demonstrating the remarkable consistency of our growth trajectory. We will continue to capitalize on the powerful health and wellness consumer trends, including the surge in GLP-1 medication use and gut health awareness. We are investing heavily in our marketing efforts and our manufacturing capabilities to support our accelerating velocities and future growth.”

Expanding Kefir Visibility

Lifeway has recently partnered with multiple health-focused brands to feature Kefir as a key ingredient in high-visibility products.

The Company partnered with Erewhon to launch the limited-edition Love Your Gut Pumpkin Spice Smoothie for the month of October, featuring Lifeway’s Organic Plain Kefir.

The Company also partnered with Joe & The Juice to create the Trust Your Gut smoothie, a functional drink made with Lifeway’s Kefir and designed to support gut health and daily wellness.

Outlook

The Company reiterated its long-term target of US$45million – US$50 million in Adjusted EBITDA for FY 2027 and is well on pace to deliver the strongest annual sales in Company history in FY 2025.

“Our momentum is accelerating,” Smolyansky concluded. “We are stacking record quarters while delivering expanding margins and on-trend innovation. We have the right team in place, are executing at the highest level, and I am confident in our ability to sustain these outstanding results.”

Subscribe to receive our email newsletters with the latest news and insights from Africa, the Middle East and around the world. SUBSCRIBE HERE